Pathologic assessment of tumor-associated macrophages and their histologic localization in invasive breast carcinoma

[1] Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424

[2] Ferlay J(2018)Tumor-associated macrophages in breast cancer: Innocent bystander or important player? Cancer Treat Rev 70 178-189

[3] Soerjomataram I(2014)Angiogenesis and the Tumor Microenvironment: Vascular Endothelial Growth Factor and Beyond Semin Oncol 41 235-251

[4] Siegel RL(2015)Immune cell promotion of metastasis Nat Rev Immunol 15 73-86

[5] Torre LA(2013)Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer Cancer Lett 332 3-10

[6] Jemal A(2012)Systematic validation of specific phenotypic markers for in vitro polarized human macrophages J Immunol Methods 375 196-206

[7] Qiu SQ(2015)Macrophages and therapeutic resistance in cancer Cancer Cell 27 462-472

[8] Waaijer SJH(2012)Tumour-infiltrating macrophages and clinical outcome in breast cancer J Clin Pathol 65 159-163

[9] Zwager MC(2018)Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer Ann Surg Oncol 25 1783-1785

[10] de Vries EGE(2011)Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 Annals of Oncology 22 1736-1747

[1] Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424

[2] Ferlay J(2018)Tumor-associated macrophages in breast cancer: Innocent bystander or important player? Cancer Treat Rev 70 178-189

[3] Soerjomataram I(2014)Angiogenesis and the Tumor Microenvironment: Vascular Endothelial Growth Factor and Beyond Semin Oncol 41 235-251

[4] Siegel RL(2015)Immune cell promotion of metastasis Nat Rev Immunol 15 73-86

[5] Torre LA(2013)Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer Cancer Lett 332 3-10

[6] Jemal A(2012)Systematic validation of specific phenotypic markers for in vitro polarized human macrophages J Immunol Methods 375 196-206

[7] Qiu SQ(2015)Macrophages and therapeutic resistance in cancer Cancer Cell 27 462-472

[8] Waaijer SJH(2012)Tumour-infiltrating macrophages and clinical outcome in breast cancer J Clin Pathol 65 159-163

[9] Zwager MC(2018)Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer Ann Surg Oncol 25 1783-1785

[10] de Vries EGE(2011)Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 Annals of Oncology 22 1736-1747